To develop rational novel drugs targeting the cancers with mutations of the cancer diver genes, we applied the computational approach to identify 40, 21, 5, 43, and 18 potential synthetic lethal genes to APC, KRAS, BRAF, PIK3CA, and TP53, respectively. This evidence concerns the gene TP53 and cancer.